Wikidata

(Q61957662)

English

Establishing Cardiovascular Biomarkers to Define Preferred Lantus® Use

clinical trial

In more languages

Statements

title
Establishing Cardiovascular Biomarkers to Define Preferred Lantus® Use. (English)
0 references
country
Germany
0 references
start time
October 2011
0 references
end time
October 2012
0 references
number of participants
60
0 references
research intervention
insulin glulisine
0 references
insulin glargine
0 references
NPH insulin
0 references
minimum age
18 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q61957662&oldid=2149431366"